Noel Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 5.00 Cr
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 43.08 Cr
About Noel Pharma (India)
Noel Pharma (India) Private Limited (NPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 November 2012 and has a history of 12 years and three months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Noel Pharma (India) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹43.08 Cr.
Venkataiah Sandrapalle and Sujatha Sandrapalle serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100TG2012PTC084182
- Company No.
084182
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Noel Pharma (India) Private Limited offer?
Noel Pharma (India) Private Limited offers a wide range of products and services, including Third Party Manufacturing Consultancy, Pharmaceutical Contract Manufacturing Services, Antibiotic Syrup & Oral Suspension, Azithromycin Suspension Syrup.
Who are the key members and board of directors at Noel Pharma (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkataiah Sandrapalle  | Managing Director | 15-Nov-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujatha Sandrapalle | Additional Director | 22-Jun-2018 | Current |
Financial Performance of Noel Pharma (India).
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Noel Pharma (India)?
Unlock access to Noel Pharma (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹43.08 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 42.89 Cr
- Electronica Finance Limited : 0.19 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 2013 | Electronica Finance Limited | ₹1.88 M | Open |
| 06 Dec 2012 | State Bank Of India | ₹42.89 Cr | Open |
How Many Employees Work at Noel Pharma (India)?
Unlock and access historical data on people associated with Noel Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noel Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noel Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
